Hangzhou AGS MedTech Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 18.93%

Hangzhou AGS MedTech Co. Ltd. A (688581) has an Asset Resilience Ratio of 18.93% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Hangzhou AGS MedTech Co. Ltd. A carry for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥500.86 Million
≈ $73.29 Million USD Cash + Short-term Investments

Total Assets

CN¥2.65 Billion
≈ $387.24 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Hangzhou AGS MedTech Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688581 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Hangzhou AGS MedTech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hangzhou AGS MedTech Co. Ltd. A (688581) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥500.86 Million 18.93%
Total Liquid Assets CN¥500.86 Million 18.93%

Asset Resilience Insights

  • Good Liquidity Position: Hangzhou AGS MedTech Co. Ltd. A maintains a healthy 18.93% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Hangzhou AGS MedTech Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Hangzhou AGS MedTech Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
Vieworks Co. Ltd
KQ:100120
Medical Devices 7.81%
Lumos Diagnostics Holdings Ltd
AU:LDX
Medical Devices 9.40%
Humasis Co. Ltd
KQ:205470
Medical Devices 52.35%
DRGEM Corporation
KQ:263690
Medical Devices 0.50%
aap Implantate AG
F:AAQ1
Medical Devices 3.55%
Cochlear Ltd
AU:COH
Medical Devices 9.76%

Annual Asset Resilience Ratio for Hangzhou AGS MedTech Co. Ltd. A (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Hangzhou AGS MedTech Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 26.32% CN¥671.22 Million
≈ $98.22 Million
CN¥2.55 Billion
≈ $373.11 Million
+22.79pp
2023-12-31 3.54% CN¥82.42 Million
≈ $12.06 Million
CN¥2.33 Billion
≈ $341.11 Million
-8.09pp
2022-12-31 11.63% CN¥55.01 Million
≈ $8.05 Million
CN¥473.13 Million
≈ $69.23 Million
+11.31pp
2021-12-31 0.32% CN¥1.09 Million
≈ $159.70K
CN¥341.99 Million
≈ $50.04 Million
--
pp = percentage points

About Hangzhou AGS MedTech Co. Ltd. A

SHG:688581 China Medical Devices
Market Cap
$752.37 Million
CN¥5.14 Billion CNY
Market Cap Rank
#10576 Global
#3107 in China
Share Price
CN¥63.38
Change (1 day)
+5.11%
52-Week Range
CN¥52.48 - CN¥87.93
All Time High
CN¥92.52
About

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; an… Read more